Home > Healthcare > Medical Devices > Surgical Devices > Endoscopy Fluid Management Market

Endoscopy Fluid Management Market Trends

Report ID: GMI4281
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Endoscopy Fluid Management Market Trends

The incorporation of innovative technologies into fluid management systems contributes to the market's evolution, meeting the evolving needs of healthcare providers and improving patient outcomes.

Advancements in imaging technologies, including high-definition (HD) and ultra-high-definition (UHD) imaging, provide clearer and more detailed visuals during endoscopic procedures. For instance, in September 2020, Olympus Corporation introduced the EVIS X1 endoscopy system. This system features the ENDO-AID platform, which uses artificial intelligence to enhance endoscopic imaging and fluid management. The improved visualization enhances the accuracy of diagnoses and interventions, necessitating fluid management systems that can accommodate the enhanced imaging capabilities.
Moreover, technological innovations in hysteroscopy fluid management systems are tailored to the unique requirements of hysteroscopic procedures, which involve the visualization and treatment of the uterine cavity. For instance, in January 2021, Hologic, Inc. announced the European launch of its Fluent fluid management system. This system incorporates precise control mechanisms for fluid infusion and pressure regulation. This level of control is crucial in hysteroscopy to achieve optimal distention of the uterine cavity and improve the accuracy of diagnostic assessments and surgeries.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global endoscopy fluid management industry was valued at around USD 866.6 million in 2023 and is expected to expand at a CAGR of 7.2% during 2024-2032, attributed to the increasing prevalence of chronic diseases requiring endoscopic procedures, coupled with the rising demand for minimally invasive procedures.

The endoscopy fluid management systems segment is expected to record over 84.4% market share in 2023 and is anticipated to witness significant growth through 2032 as these systems prioritize patient safety by incorporating features that minimize the risk of fluid-related complications.

North America endoscopy fluid management industry accounted for USD 290.4 million in 2023 and is predicted to witness substantial arket growth through 2032 driven by the increasing disease prevalence, a preference for minimally invasive procedures, strong healthcare infrastructure, and adherence to regulatory standards.

Arthrex, Inc., B. Braun SE, CONMED Corporation, Hologic Inc., Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew, STERIS plc, and Stryker Corporation.